Women with irregular periods should be checked for PMOS, NHS says

Millions of Women at Risk of Misdiagnosed Condition: New NHS Guidance Calls for Increased Screening. A shocking revelation from the National Institute for Health and Care Excellence (Nice) suggests that polyendocrine metabolic ovarian syndrome (PMOS), previously thought to be a relatively rare condition, is in fact far more widespread than initially believed. Estimated to affect up to 13% of reproductive-aged women, or approximately 4 million women in the UK, PMOS is a complex condition characterized by irregular periods, among other symptoms. The new guidance recommends that women with irregular periods be investigated for PMOS, highlighting the need for more consistent and effective management of this often underdiagnosed condition.

Polyendocrine metabolic ovarian syndrome is underdiagnosed and inconsistenly managed, according to NiceUp to 4 million women with irregular periods should be investigated for polyendocrine metabolic ovarian syndrome, according to new NHS guidance.PMOS, previously known as polycystic ovarian syndrome, is believed to affect up to 13% of reproductive age women, the World Health Organization estimates. Continue reading...